Shares of ResMed Inc. RMD inched 0.51% higher to $246.18 Monday, on what proved to be an all-around great trading session for ...

Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost ...

Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.

To get a sense of who is truly in control of ResMed Inc. ( NYSE:RMD ), it is important to understand the ownership structure ...

ResMed's AirSense 11 platform and myAir app enhance patient engagement and efficiency. Check out why I remain bullish on RMD ...

根据最近的SEC文件显示，ResMed Inc.（纽交所代码：RMD）的首席商务官（SaaS）Kaushik Ghoshal于9月12日出售了公司5,000股股票，净收入超过120万美元。这些股票以平均252.56美元的价格售出，交易总额为1,262,800美元。

ResMed Inc. (NYSE:RMD) 报告称，其首席财务官Brett Sandercock于2024年9月9日出售了公司股票。根据文件显示，Sandercock以每股246.42美元的价格出售了1,000股ResMed普通股，总计246,420美元。

ResMed achieved double-digit revenue growth through acquisitions and operating efficiencies, with improving capital ...

Polark's pessimism stems from concerns that Resmed might be poised to lose market share to its pharmaceutical rival Eli Lilly ...

Shares of ResMed Inc. RMD inched 0.81% higher to $244.94 Friday, on what proved to be an all-around mixed trading session for ...

ResMed faces a 3% drop in share price after concerns over Eli Lilly’s Ozempic, which could impact the demand for CPAP ...

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...